Nurix therapeutics announces closing of public offering and full exercise of underwriters' option to purchase additional shares

San francisco, april 16, 2024 (globe newswire) -- nurix therapeutics, inc. (nasdaq: nrix) today announced the closing of its underwritten public offering of 11,916,667 shares of its common stock at a public offering price of $15.00 per share, which includes 1,750,000 shares issued upon the exercise in full by the underwriters of their option to purchase additional shares of common stock. in addition, and in lieu of common stock, nurix sold to certain investors pre-funded warrants to purchase 1,500,100 shares of common stock at a purchase price of $14.999 per pre-funded warrant, which represents the per share public offering price for the common stock less the $0.001 per share exercise price for each such pre-funded warrant. the net proceeds from the offering, after deducting underwriting discounts and commissions and other offering expenses, were approximately $188.6 million.
NRIX Ratings Summary
NRIX Quant Ranking